About
Built on evidence.
Driven by impact.
Geneva-based, globally active. A knowledge-driven institute with a research core, a learning platform, an AI capability, and a strategic advisory practice.
Our mission
Helix Global Institute exists to close the gap between the best available evidence and the health systems that need it most.
Through research, learning, and expert advisory, we accelerate the prevention and control of noncommunicable diseases in low- and middle-income countries — and build the human and institutional capacity to sustain that progress.
It is not a generic consultancy. It is a knowledge-driven institute with a research core, a learning platform, an AI capability, and a strategic advisory practice — all unified under one identity, serving governments, international institutions, health ministries, academic bodies, and health professionals worldwide.
Our vision
A world in which the quality of a person's health is no longer determined by where they were born — and in which the scientific evidence needed to prevent the leading causes of premature death reaches every health system that needs it.
What guides us
Our values
Evidence
Every recommendation is grounded in peer-reviewed science. We do not advise on opinion; we advise on evidence.
Equity
Our work prioritises the populations most affected by preventable disease — those in low- and middle-income countries where the burden is highest and resources are least.
Rigour
We hold ourselves to the standards of the journals we publish in. Every analysis, every advisory, every course is produced to the highest methodological standard.
Accessibility
We make complex knowledge usable. The best evidence is worthless if the people who need it cannot access, understand, or apply it.
Founder & Scientific Director
Dr Kouamivi Agboyibor
MD, MPH, PhD · Geneva, Switzerland
Dr Kouamivi Agboyibor is the Founder and Scientific Director of Helix Global Institute and Technical Lead for the Cardiovascular Disease Management Programme at the World Health Organization Headquarters in Geneva, Switzerland.
Dr Agboyibor is among the leading epidemiologists working on cardiovascular diseases and noncommunicable diseases. His research programme spans cardiovascular disease epidemiology, hypertension control, obesity trends, and the implementation science of primary health care in low-resource settings. His work has been published in JACC, JAMA Cardiology, BMJ Global Health, The Lancet, and eClinicalMedicine, among others.
Bilingual communicator, his landmark multi-country analyses — drawing on WHO STEPS survey data from 37 African countries and covering over 156 million adults — have generated the most comprehensive epidemiological evidence base on cardiovascular disease trends in the WHO African Region to date, informing national policy in more than two dozen countries.
Where we work
Helix Global Institute is headquartered in Geneva, Switzerland — the global capital of international public health. We work wherever the evidence-to-action gap is widest: with governments, ministries, international institutions, and health professionals in every region of the world.
The institute operates as an independent institute and consultancy, and all advisory work is conducted in full compliance with applicable institutional policies.